Inflammation

What inflammation actually is

Inflammation is not a disease — it is a coordinated emergency response that your tissues mount the instant something goes wrong. Cut your finger, twist an ankle, catch a splinter, or get colonized by bacteria, and within seconds a chemical alarm starts spreading from the damaged site. The goal is simple and ancient: get the blood's defensive machinery — fluid, antibodies, complement proteins, and white blood cells — out of the vessels and into the tissue where the threat is, isolate the damage, kill or wall off any invaders, clear the debris, and then rebuild. Every step you can see and feel maps onto a specific molecular cause.

The four signs the Roman encyclopedist Aulus Cornelius Celsus wrote down around 30 AD — rubor (redness), calor (heat), tumor (swelling), and dolor (pain) — are still the bedside definition. A fifth, functio laesa (loss of function), was added later. They are not symptoms of something going wrong with the response; they are the response. Redness and heat are the extra warm blood. Swelling is the plasma that has deliberately leaked out. Pain is your nervous system being told, chemically, to protect the area. Understanding inflammation means reading those four signs back into the cells and molecules that produce them.

How the response unfolds, step by step

Detection (seconds). Tissue damage and pathogens are sensed by resident sentinel cells — chiefly mast cells, macrophages, and dendritic cells. They carry pattern-recognition receptors, especially the Toll-like receptors (TLRs), that bind conserved microbial molecules (PAMPs — pathogen-associated molecular patterns, like bacterial LPS via TLR4) and molecules spilled by dying host cells (DAMPs — damage-associated molecular patterns, like ATP, uric acid, and HMGB1). Damage also directly activates plasma cascades: the complement system and the kinin system.

Vasodilation (seconds to minutes). Mast cells degranulate and dump preformed histamine, which binds H1 receptors on the smooth muscle of arterioles, relaxing them. Local blood flow can rise several-fold. This is the redness and the warmth. Nitric oxide from endothelium reinforces the dilation.

Increased permeability (minutes). Histamine, plus newly made bradykinin and leukotrienes, makes the endothelial cells of post-capillary venules contract and pull apart, opening gaps roughly 0.1–1 µm wide. Protein-rich plasma — water, albumin, fibrinogen, antibodies, complement — leaks into the interstitium as exudate. That is the swelling. The escaped fibrinogen polymerizes into a fibrin mesh that walls off the zone and scaffolds repair.

Amplification (minutes to hours). Activated macrophages secrete the master pro-inflammatory cytokines TNF-α, IL-1β, and IL-6. Membrane phospholipids are cleaved by phospholipase A2 into arachidonic acid, which cyclooxygenase (COX-1/COX-2) turns into prostaglandins (PGE2 amplifies pain, fever, and vasodilation) and which 5-lipoxygenase turns into leukotrienes. Complement fragments C3a and C5a act as anaphylatoxins and chemoattractants.

Recruitment (1–48 hours). TNF-α and IL-1β order the endothelium to display adhesion molecules. Neutrophils roll, stick, and crawl out of the vessels first (peak 6–24 h), releasing antimicrobial peptides, reactive oxygen species via the respiratory burst, and NETs (neutrophil extracellular traps). Monocytes follow and mature into tissue macrophages over 24–48 h, phagocytosing pathogens and dead neutrophils.

Resolution (days). A clean acute response actively switches itself off. The same arachidonic acid is rerouted into specialized pro-resolving mediators — lipoxins, resolvins, protectins, maresins — that stop neutrophil recruitment, reprogram macrophages to an anti-inflammatory, debris-clearing (efferocytic) state, and trigger tissue repair. Resolution is a program, not a passive fade-out.

The leukocyte adhesion cascade — how cells leave the blood

White blood cells travel sealed inside vessels at high speed. Getting them out at exactly the right spot is a precise four-step handshake that happens at post-capillary venules, where the wall is thinnest and the flow slowest:

1. Rolling. Inflamed endothelium puts out P-selectin (from Weibel-Palade bodies, within minutes) and E-selectin (newly synthesized, within hours). These grab sugar ligands like PSGL-1 on the neutrophil, forming bonds that catch and release — so the cell tumbles slowly along the wall instead of zipping past.
2. Activation. Chemokines such as IL-8 (CXCL8) displayed on the endothelial surface signal through the neutrophil's G-protein-coupled receptors, switching its integrins (LFA-1, Mac-1) from a bent low-affinity state to an extended high-affinity one within milliseconds.
3. Firm adhesion. The now-sticky integrins clamp onto endothelial ICAM-1, arresting the cell against the shear of flowing blood.
4. Transmigration (diapedesis). The neutrophil flattens and squeezes between (or straight through) endothelial cells, crosses the basement membrane, and then crawls up a chemoattractant gradient — C5a, IL-8, bacterial fMLP peptides, and leukotriene B4 — straight to the source of trouble.

The clinical proof that this matters: people with leukocyte adhesion deficiency (LAD-1), who lack the integrin β2 subunit, cannot get neutrophils out of the blood. They suffer recurrent, life-threatening bacterial infections and — tellingly — cannot form pus or detach the umbilical cord on time, because pus is mostly accumulated neutrophils.

The molecular and cellular cast

Player	Type	Source	Main job in inflammation
Histamine	Vasoactive amine	Mast cells, basophils (preformed granules)	Immediate vasodilation + venule permeability
Prostaglandin E2	Eicosanoid	COX-1/COX-2 on arachidonic acid	Pain, fever, vasodilation
Leukotriene B4	Eicosanoid	5-lipoxygenase	Potent neutrophil chemoattractant
Bradykinin	Peptide	Kinin (kallikrein) cascade in plasma	Pain, permeability, vasodilation
C3a / C5a	Complement fragments	Complement cascade	Anaphylatoxins; C5a is a strong chemoattractant
TNF-α	Cytokine	Activated macrophages	Endothelial activation, fever, cachexia
IL-1β	Cytokine	Macrophages (via inflammasome)	Fever, adhesion molecules, acute-phase response
IL-6	Cytokine	Macrophages, T cells	Drives hepatic acute-phase proteins (CRP)
Neutrophil	Cell (granulocyte)	Bone marrow → blood	First responder; phagocytosis, ROS, NETs
Macrophage	Cell (mononuclear)	Blood monocyte → tissue	Sustained phagocytosis, cytokines, repair

Acute vs chronic inflammation

Property	Acute inflammation	Chronic inflammation
Onset	Fast (minutes–hours)	Slow (days–weeks)
Duration	Hours to a few days	Weeks to years
Dominant cells	Neutrophils	Macrophages, lymphocytes, plasma cells
Tissue change	Exudate, edema, fibrin	Tissue destruction + fibrosis + angiogenesis at once
Vascular response	Prominent (vasodilation, leak)	Less prominent
Outcome	Resolution, abscess, or progression	Scarring, granuloma, organ damage
Hallmark trigger	Infection, trauma, burn	Persistent infection, autoimmunity, indigestible irritant
Classic example	Bacterial skin infection (cellulitis)	Tuberculosis granuloma, rheumatoid synovitis, atherosclerotic plaque

Inflammation by the numbers

• Histamine acts in seconds. Mast-cell granules release preformed histamine almost instantly; the vasodilation and wheal of a mosquito bite or a positive skin-prick test appear within 1–2 minutes and peak by ~15 minutes.
• Neutrophils peak at 6–24 hours. They are the most abundant white cell (40–70% of ~4,000–11,000 leukocytes per µL of blood) and the first on scene; macrophages take over after 24–48 hours and dominate by day 2–3.
• Venule gaps are 0.1–1 µm. The endothelial gaps opened by histamine and bradykinin are wide enough to pass plasma protein (albumin is ~3.5 nm, fibrinogen ~45 nm long) but the leak is reversible within an hour for the immediate-transient response.
• Exudate vs transudate by density. Inflammatory exudate has a specific gravity above 1.020 and protein over ~3 g/dL, versus transudate (heart failure, low albumin) below 1.012 — a number that decides diagnoses at the bedside.
• CRP can rise 1,000-fold. Driven by IL-6, hepatic C-reactive protein climbs from a baseline under 1 mg/L to over 100–500 mg/L within 24–48 hours of major inflammation — the standard blood marker doctors track. Serum amyloid A behaves similarly.
• Fever set-point shift. IL-1, IL-6, and TNF-α (and prostaglandin E2) raise the hypothalamic set point; a 1 °C rise (37 → 38 °C) measurably slows many bacteria and speeds lymphocyte function. This is why blocking PGE2 with an NSAID brings fever down.
• Neutrophil lifespan is short. Circulating neutrophils live only ~6–8 hours in blood and a few days in tissue; their death and clearance, not just their arrival, is what determines whether inflammation resolves or festers into pus.
• Chronic inflammation is a mass killer. Inflammatory mechanisms are central to the diseases behind a large share of global deaths — heart disease (atherosclerosis), stroke, type 2 diabetes, and many cancers all have a chronic inflammatory component.

Where it shows up — diseases and examples

• Atherosclerosis. Far from a passive plumbing problem, arterial plaque is a chronic inflammatory lesion: macrophages engulf oxidized LDL, become foam cells, and secrete cytokines. The CANTOS trial (2017) showed that blocking IL-1β with canakinumab cut cardiovascular events independently of cholesterol — direct proof inflammation drives heart attacks.
• Rheumatoid arthritis. Autoimmune inflammation of the joint synovium, driven heavily by TNF-α. Anti-TNF biologics (infliximab, adalimumab, etanercept) and IL-6 blockade (tocilizumab) transformed treatment.
• Gout. Uric-acid crystals are sensed by the NLRP3 inflammasome, which activates caspase-1 to mature IL-1β — explaining the sudden, excruciating joint inflammation and why IL-1 blockers help.
• Sepsis and cytokine storm. An overwhelming, body-wide release of TNF-α, IL-1, and IL-6 causes systemic vasodilation, capillary leak, shock, and organ failure. The same runaway cytokine release made severe COVID-19 lethal and made IL-6 blockade (tocilizumab) and dexamethasone life-saving.
• Inflammatory bowel disease. Crohn's disease and ulcerative colitis are chronic intestinal inflammation; anti-TNF and anti-integrin (vedolizumab, which blocks the very adhesion cascade described above) drugs are mainstays.
• Cancer. Rudolf Virchow noted in 1863 that tumors arise at sites of chronic inflammation. Chronic hepatitis → liver cancer, H. pylori gastritis → stomach cancer, and chronic colitis → colorectal cancer all illustrate inflammation as a tumor promoter.

Common misconceptions

• Inflammation is always bad. No — acute inflammation is essential and protective. People who cannot mount it (severe neutropenia, LAD-1) die of infection. The problem is inflammation that is excessive, misdirected (autoimmunity), or chronic.
• Swelling is just water. Inflammatory swelling is protein-rich exudate, not plain water. The leaked fibrinogen, antibodies, and complement are functional — they wall off and attack the threat. That is what distinguishes it from the bland transudate of heart failure.
• Redness and heat mean infection. The cardinal signs reflect the vascular response to any trigger — a sterile burn, a sprain, or crystal deposition in gout all produce redness, heat, swelling, and pain with no microbe present at all.
• Pus means the body is losing. Pus is mostly dead neutrophils, tissue debris, and fluid — the visible aftermath of a vigorous defense. Its absence in immunodeficiency is the dangerous sign, not its presence.
• Anti-inflammatory drugs cure the cause. NSAIDs and steroids suppress the mediators (prostaglandins, cytokines) — they relieve signs but do not remove the trigger. Masking inflammation over an untreated infection can be dangerous.
• Fever should always be suppressed. Fever is an evolved defense — a higher set point slows pathogen growth and speeds immune cells. Routinely crushing every mild fever can, in some infections, modestly prolong illness; the reason to treat is comfort or when fever itself is dangerous.
• The Na/K-pump or "toxins" drive it. Inflammation is driven by defined receptors (TLRs, the inflammasome), cytokines, eicosanoids, and adhesion molecules — a specific signaling program, not a vague buildup of toxins.